from SABCS
I have to concur with Robin,s assessment that HER2 status often upregulates especially after Hormonal therapy or dose-dense chemo. Cancer has proven to be a VERY sneaky opponent with numerous pathways to plug into when assualted. IE, cross-talk between ER and HER2 may upgrulate HER2 if the cancer is being killed by ER therapy. Likewise, if you are HER2+ and ER+ and on herceptin, you may find that ER become up-regulated. The delimma that I think many HER2 - MBC patients face is is what is the HER2 status of the mets and how do we test for it, while the least invasive method is fine-needle asperation.
The readers digest version.....if you develop MBC, don't make the assumption that HER2 status is the same as the primary tumor,,,that one could cost you dearly.
Regards,
Al
__________________
Primary care-giver to and advocate for Linda, who passed away April 27, 2006.
|